Evidence map›Paper›PMID 40918310›Full record

ReviewRSC advances2025

Diverse chemotypes of polyketides as promising antimicrobial agents: latest progress.

Gautam Kumar, Sidharth Chopra

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gautam KumarDepartment of Pharmacy, Vidya Vihar, Birla Institute of Technology and Science Pilani Pilani Campus Pilani Rajasthan 333031 India gautam.kumar@pilani.bits-pilani.ac.in.ORCID https://orcid.org/0000-0003-4047-1416
Sidharth ChopraDepartment of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute Sector 10, Janakipuram Extension, Sitapur Road Lucknow Uttar Pradesh-226031 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microorganisms, including bacteria, viruses, fungi, and protozoa, significantly impact human health by causing infections that can lead to serious health issues, including mortality and morbidity. Antimicrobials, including antibacterials, anti-virals, anti-fungals, and anti-parasitics, effectively prevent and treat infections in humans and animals. However, pathogens have developed resistance to these antimicrobials, enabling them to survive and persist even in the presence of antibiotics. There is a pressing need to develop new antibiotics with different mechanisms of action to combat infectious diseases effectively. Nature provides a vast therapy and drug discovery resource, offering unparalleled chemical diversity and structural complexity. Among these resources, polyketide synthase machinery produces secondary metabolites in plants, animals, marine organisms, and fungi, significantly contributing to drug discovery. Notably, polyketides exhibit diverse chemotypes, which can facilitate the discovery of antimicrobial drugs. Also, polyketide-based drugs, including anti-bacterial, anti-fungal, and anti-parasitic, have been approved for treating various infectious diseases. This review summarizes recently identified natural polyketides with potential antimicrobial activities.

Identifiers

PMID40918310
PMCPMC12412674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.